BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9794603)

  • 1. Malonyldialdehyde content of cell membranes is the most important marker of oxidative stress in haemodialysis patients.
    Taccone-Gallucci M; Lubrano R; Meloni C; Morosetti M; Adolfo CM; Casciani CU
    Nephrol Dial Transplant; 1998 Oct; 13(10):2711-2. PubMed ID: 9794603
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation.
    Túri S; Németh I; Varga I; Matkovics B
    Nephrol Dial Transplant; 1999 Jan; 14(1):252-3. PubMed ID: 10052534
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation.
    Taccone-Gallucci M; Lubrano R; Del Principe D; Menichelli A; Giordani M; Citti G; Morosetti M; Meloni C; Mazzarella V; Meschini L
    Nephrol Dial Transplant; 1989; 4(11):975-8. PubMed ID: 2516890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell membrane oxidative damage and renal impairment in uremic patients under conservative treatment.
    Lubrano R; Meloni C; di Villahermosa SM; Morosetti M; Taccone-Gallucci M
    Nutrition; 2000 Jan; 16(1):86. PubMed ID: 10674251
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin E and selenium co-supplementation attenuates oxidative stress in haemodialysis patients receiving intra-dialysis iron infusion.
    Ardalan MR; Tubbs RS; Shoja MM
    Nephrol Dial Transplant; 2007 Mar; 22(3):973-5. PubMed ID: 17085466
    [No Abstract]   [Full Text] [Related]  

  • 6. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
    Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in red blood cell sodium and potassium concentrations and increased lipid peroxidation in patients with chronic renal failure on maintenance hemodialysis: a hypothesis.
    Paskalev D; Tchankova P; Jankova T; Steiner M; Nenov D
    Am J Nephrol; 1994; 14(3):246-8. PubMed ID: 7832914
    [No Abstract]   [Full Text] [Related]  

  • 8. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients.
    Yalçin AS; Yurtkuran M; Dilek K; Kilinç A; Taga Y; Emerk K
    Clin Chim Acta; 1989 Oct; 185(1):109-12. PubMed ID: 2620447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin E-coated membrane dialysers on inflammation and oxidative stress in maintenance haemodialysis patients.
    Filiopoulos V; Takouli L; Vlassopoulos D
    Nephrol Dial Transplant; 2011 Sep; 26(9):3064-5; author reply 3065. PubMed ID: 21750164
    [No Abstract]   [Full Text] [Related]  

  • 11. Red blood cell membrane lipid peroxidation and chronic haemolysis in haemodialysis patients.
    Taccone-Gallucci M; Lubrano R; Mazzarella V; Bandino D; Meloni C; Morosetti M; Elli M; Giardini O; Boffo V; Tozzo C
    Life Support Syst; 1985; 3 Suppl 1():41-4. PubMed ID: 3870599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte transmembrane electron transfer in haemodialysis patients.
    Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in haemodialysis.
    Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER
    QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
    Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
    Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of erythropoietin in predialysis patients.
    Anderson S
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
    Tutal E; Sezer S; Bilgic A; Aldemir D; Turkoglu S; Demirel O; Ozdemir N; Haberal M
    Transplant Proc; 2007 Dec; 39(10):3035-40. PubMed ID: 18089316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients.
    Stenvinkel P; Holmberg I; Heimbürger O; Diczfalusy U
    Nephrol Dial Transplant; 1998 Oct; 13(10):2594-600. PubMed ID: 9794566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.